Company intelligence / Profile preview
KisoJi Biotechnology Inc.
Toronto, Ontario, Canadakisojibiotech.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Lead candidate KJ-103 (a naked anti-TROP2 single domain antibody) has demonstrated significant anti-tumor potency with no evidence of toxicity or resistance in preclinical solid tumor models. A Phase 1/2a clinical trial in approximately 100 patients with TROP2-expressing solid tumors will be conducted in partnership with Cancer Research UK. The company’s platform enables rapid generation of highly diverse and manufacturable multi-specific antibodies using advanced AI tools
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- Single domain antibodiesmulti-specific antibodiesmonoclonal antibodies (“naked” mAbs)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Cancer Research UK – clinical development partnership for first-in-human trial of lead assetLifeArc – humanization of the lead antibody candidateadMare BioInnovations – portfolio company relationship/supporter
Beyond the preview
Go deeper on KisoJi Biotechnology Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KisoJi Biotechnology Inc..